Poland· PL-100129802
Stalevo
A levodopa, decarboxylasehemmer und comt-hemmer product containing levodopum + carbidopum + entacaponum, registered in Poland by Orion Corporation. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Levodopa, decarboxylasehemmer und comt-hemmer is registered in 12 of 19 countries.
Countries holding a registration under ATC N04BA03 (levodopa, decarboxylasehemmer und comt-hemmer), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Levodopa, decarboxylasehemmer und comt-hemmer · ATC N04BA03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of levodopa, decarboxylasehemmer und comt-hemmer costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), the median price runs from $1.36 in Italy to $5.49 in Switzerland — a ×4.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levodopa, decarboxylasehemmer und comt-hemmer · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.49
- IT Italy$1.36
The record
At a glance
URPL (Poland)- Active substance
- Levodopum + Carbidopum + Entacaponum
- Manufacturer
- Orion Corporation
- Country
- Poland (PL)
- ATC code
- N04BA03
- ATC class
- Levodopa, Decarboxylasehemmer und COMT-Hemmer
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990010974
- gtin05909990010981
- gtin05909990010998
- gtin05909990010967
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for levodopa, decarboxylasehemmer und comt-hemmer.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levodopa, decarboxylasehemmer und comt-hemmer · interactions on record
158 records
- 4 severe
- 122 moderate
- 14 minor
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Methylthioninium chlorideV03AB17severe
18 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N04BA03
Levodopa, decarboxylasehemmer und comt-hemmer, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dec39299-b8c6-4dc3-bfce-daffe08c1d26 GET /v1/drugs/dec39299-b8c6-4dc3-bfce-daffe08c1d26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 12,5 mg + 200 mg",
"packaging": "05909990010967 ¦ Rp ¦ EU/1/03/260/001 ¦ 24852\n1 butelka 10 tabl.\n05909990010974 ¦ Rp ¦ EU/1/03/260/002 ¦ 24853\n1 butelka 30 tabl.\n05909990010981 ¦ Rp ¦ EU/1/03/260/003 ¦ 24854\n1 butelka 100 tabl.\n05909990010998 ¦ Rp ¦ EU/1/03/260/004 ¦ 24855\n1 butelka 250 tabl.\nRp ¦ EU/1/03/260/016 ¦ 105617\n1 butelka 130 tabl.\nRp ¦ EU/1/03/260/013 ¦ 105618\n1 butelka 175 tabl.",
"substance": "Levodopum 50 mg + Carbidopum 12.5 mg + Entacaponum 200 mg",
"common_name": "Levodopum + Carbidopum + Entacaponum",
"pl_product_id": "100129802",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about levodopa, decarboxylasehemmer und comt-hemmer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.